Kinetics of lethal factor and poly-D-glutamic acid antigenemia during inhalation anthrax in rhesus macaques

Infection and Immunity

Volumn 77, Issue 8, 2009, Pages 3432-3441

  Boyer, Anne E ^a,b   Quinn, Conrad P ^a,c   Hoffmaster, Alex R ^a,d   Kozel, Thomas R ^e   Saile, Elke ^a,c   Marston, Chung K ^a,d   Percival, Ann ^e   Plikaytis, Brian D ^a,c   Woolfitt, Adrian R ^a,b   Gallegos, Maribel ^a,b,f   Sabourin, Patrick ^f   McWilliams, Lisa G ^a,b,f   Pirkle, James L ^a,b   Barr, John R ^a,b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NATIONAL CENTER FOR ENVIRONMENTAL HEALTH   (United States)

^c NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^d NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^e UNIVERSITY OF NEVADA SCHOOL OF MEDICINE   (United States)

^f BATTELLE MEMORIAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; POLYGLUTAMIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTHRAX; ANTIGEN BLOOD LEVEL; ARTICLE; BACILLUS ANTHRACIS; BACTEREMIA; BACTERIAL GENE; BLOOD ANALYSIS; BLOOD DISEASE; CONTROLLED STUDY; FEMALE; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; LETHAL GENE; LYMPHOCYTE; MASS SPECTROMETRY; NEUTROPHIL; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTECTIVE ANTIGEN GENE; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RHESUS MONKEY; SURVIVAL RATE; TOXEMIA;

ANIMALS; ANTHRAX; ANTIGENS, BACTERIAL; BACTERIAL TOXINS; DNA, BACTERIAL; FEMALE; INHALATION; LEUKOCYTE COUNT; MACACA MULATTA; NEUTROPHILS; POLYGLUTAMIC ACID; POLYMERASE CHAIN REACTION;

EID: 67651227332     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00346-09     Document Type: Article

References (50)

1. Agrawal, A., J. Lingappa, S. H. Leppla, S. Agrawal, A. Jabbar, C. Quinn, and B. Pulendran. 2003. Impairment of dendritic cells and adaptive immunity by anthrax lethal toxin. Nature 424:329-334.
2. Ardron, M. J., J. C. Westengard, and T. F. Dutcher. 1994. Band neutrophil counts are unnecessary for the diagnosis of infection in patients with normal total leukocyte counts. Am. J. Clin. Pathol. 102:646-649.
3. Bischof, T. S., B. L. Hahn, and P. G. Sohnle. 2007. Experimental cutaneous Bacillus anthracis infections in hairless HRS/J mice. Int. J. Exp. Pathol. 88:75-84.
4. Boyer, A. E., C. P. Quinn, A. R. Woolfitt, J. L. Pirkle, L. G. McWilliams, K. L. Stamey, D. A. Bagarozzi, J. C. Hart, Jr., and J. R. Barr. 2007. Detection and quantification of anthrax lethal factor in serum by mass spectrometry. Anal. Chem. 79:8463-8470.
5. Brachman, P. S. 1980. Inhalation anthrax. Ann. N. Y. Acad. Sci. 353:83-93.
6. Carrero, J. A., B. Calderon, and E. R. Unanue. 2006. Lymphocytes are detrimental during the early innate immune response against Listeria monocytogenes. J. Exp. Med. 203:933-940.
7. Carrero, J. A., and E. R. Unanue. 2006. Lymphocyte apoptosis as an immune subversion strategy of microbial pathogens. Trends Immunol. 27:497-503.
8. Centers for Disease Control and Prevention. 2002. Use of anthrax vaccine in response to terrorism: supplemental recommendations of the advisory committee on immunization practices. MMWR Morb. Mortal. Wkly. Rep. 51:1024-1026.
9. Centers for Disease Control and Prevention. 2000. Use of anthrax vaccine in the United States: recommendations of the advisory committee on immunization practices. MMWR Recommend. Rep. 49(RR-15):1-20.
10. Doherty, D. E., G. P. Downey, G. S. Worthen, C. Haslett, and P. M. Henson. 1988. Monocyte retention and migration in pulmonary inflammation. Requirement for neutrophils. Lab. Investig. 59:200-213.
11. Glomski, I. J., A. Piris-Gimenez, M. Huerre, M. Mock, and P. L. Goossens. 2007. Primary involvement of pharynx and Peyer's patch in inhalational and intestinal anthrax. PLoS Pathog. 3:e76.
12. Gossett, K. A., P. S. MacWilliams, and B. Cleghorn. 1985. Sequential morphological and quantitative changes in blood and bone marrow neutrophils in dogs with acute inflammation. Can. J. Comp. Med. 49:291-297.
13. Goto, Y., J. C. Hogg, T. Suwa, K. B. Quinlan, and S. F. van Eeden. 2003. A novel method to quantify the turnover and release of monocytes from the bone marrow using the thymidine analog 5′-bromo-2′-deoxyuridine. Am. J. Physiol. Cell Physiol. 285:C253-C259.
14. Hornung, R. W., and L. D. Reed. 1990. Estimation of average concentration in the presence of nondetectable values. Appl. Occup. Environ. Hug. 5:46-51.
15. Ivins, B. E., P. F. Fellows, M. L. M. Pitt, J. E. Estep, S. L. Welkos, P. L. Worsham, and A. M. Friedlander. 1996. Efficacy of a standard human anthrax vaccine against Bacillus anthracis aerosol spore challenge in rhesus monkeys. Salisbury Med. Bull. 87(Suppl. 7):125-126.
16. Jendrek, S., S. F. Little, S. Hem, G. Mitra, and S. Giardina. 2003. Evaluation of the compatibility of a second generation recombinant anthrax vaccine with aluminum-containing adjuvants. Vaccine 21:3011-3018.
17. Jernigan, D. B., P. L. Raghunathan, B. P. Bell, R. Brechner, E. A. Bresnitz, J. C. Butler, M. Cetron, M. Cohen, T. Doyle, M. Fischer, C. Greene, K. S. Griffith, J. J. Guarner, J. L. Hadler, J. A. Hayslett, R. Meyer, L. R. Petersen, M. Phillips, R. Pinner, T. Popovic, C. P. Quinn, J. Reefhuis, D. Reissman, N. Rosenstein, A. Schuchat, W. J. Shieh, L. Siegal, D. L. Swerdlow, F. C. Tenover, M. Traeger, J. W. Ward, I. Weisfuse, S. Wiersma, K. Yeskey, S. Zaki, D. A. Ashford, B. A. Perkins, S. Ostroff, J. Hughes, D. Fleming, J. P. Koplan, J. L. Gerberding, and the National Anthrax Epidemiologic Investigation Team. 2002. Investigation of bioterrorism-related anthrax, United States, 2001: epidemiologic findings. Emerg. Infect. Dis. 8:1019-1028.
18. Jernigan, J. A., D. S. Stephens, D. A. Ashford, C. Omenaca, M. S. Topiel, M. Galbraith, M. Tapper, T. L. Fisk, S. Zaki, T. Popovic, R. F. Meyer, C. P. Quinn, S. A. Harper, S. K. Fridkin, J. J. Sejvar, C. W. Shepard, M. McConnell, J. Guarner, W. J. Shieh, J. M. Malecki, J. L. Gerberding, J. M. Hughes, B. A. Perkins, and the Anthrax Bioterrorism Investigation Team. 2001. Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States. Emerg. Infect. Dis. 7:933-944.
19. Joellenbeck, L. M., L. L. Zwanziger, J. S. Durch, and B. S. Strom. 2002. The anthrax vaccine. Is it safe? Does it work? National Academy Press, Washington, DC.
20. Kaufmann, S. H. E., A. Sher, and R. Ahmed. 2002. Immunology of infectious diseases. ASM Press, Washington, DC.
21. Kim, C., N. Gajendran, H. W. Mittrücker, M. Weiwad, Y. H. Song, R. Hurwitz, M. Wilmanns, G. Fischer, and S. H. Kaufmann. 2005. Human alpha-defensins neutralize anthrax lethal toxin and protect against its fatal consequences. Proc. Natl. Acad. Sci. USA 102:4830-4835.
22. Kobayashi, S. D., J. M. Voyich, C. Burlak, and F. R. DeLeo. 2005. Neutrophils in the innate immune response. Arch. Immunol. Ther. Exp. (Warsaw) 53:505-517.
23. Kobiler, D., S. Weiss, H. Levy, M. Fisher, A. Mechaly, A. Pass, and Z. Altboum. 2006. Protective antigen as a correlative marker for anthrax in animal models. Infect. Immun. 74:5871-5876.
24. Kozel, T. R., W. J. Murphy, S. Brandt, B. R. Blazar, J. A. Lovchik, P. Thorkildson, A. Percival, and C. R. Lyons. 2004. mAbs to Bacillus anthracis capsular antigen for immunoprotection in anthrax and detection of antigenemia. Proc. Natl. Acad. Sci. USA 101:5042-5047.
25. Krise, G. M. 1960. Hematology of the normal monkey. Ann. N. Y. Acad. Sci. 85:803-810.
26. Mabry, R., K. Brasky, R. Geiger, R. Carrion, Jr., G. B. Hubbard, S. Leppla, J. L. Patterson, G. Georgiou, and B. L. Iverson. 2006. Detection of anthrax toxin in the serum of animals infected with Bacillus anthracis by using engineered immunoassays. Clin. Vaccine Immunol. 13:671-677.
27. Martineau, A. R., S. M. Newton, K. A. Wilkinson, B. Kampmann, B. M. Hall, N. Nawroly, G. E. Packe, R. N. Davidson, C. J. Griffiths, and R. J. Wilkinson. 2007. Neutrophil-mediated innate immune resistance to mycobacteria. J. Clin. Investig. 117:1988-1994.
28. Maung, A. A., S. Fujimi, M. P. MacConmara, G. Tajima, A. M. McKenna, A. J. Delisle, C. Stallwood, A. B. Onderdonk, J. A. Mannick, and J. A. Lederer. 2008. Injury enhances resistance to Escherichia coli infection by boosting innate immune system function. J. Immunol. 180:2450-2458.
29. Mayer-Scholl, A. 2006. A review of the interaction of Bacillus anthracis with cells of the innate immune response. Berl. Munch. Tierarztl. Wochenschr. 119:216-221.
30. Mayer-Scholl, A., R. Hurwitz, V. Brinkmann, M. Schmid, P. Jungblut, Y. Weinrauch, and A. Zychlinsky. 2005. Human neutrophils kill Bacillus anthracis. PLoS Pathog. 1:e23.
31. Moayeri, M., J. F. Wiggins, and S. H. Leppla. 2007. Anthrax protective antigen cleavage and clearance from the blood of mice and rats. Infect. Immun. 75:5175-5184.
32. Mock, M., and T. Mignot. 2003. Anthrax toxins and the host: a story of intimacy. Cell. Microbiol. 5:15-23.
33. O'Connell, M. A., B. A. Belanger, and P. D. Haaland. 1993. Calibration and assay development using the four-parameter logistic model. Chemometrics Intelligent Lab. Syst. 20:97-114.
34. Peterman, J. H. 1991. Immunochemical considerations in the analysis of data from non-competitive solid-phase immunoassays, p. 47-65. In J. E. Butler (ed.), Immunochemistry of solid-phase immunoassay. CRC Press, Inc., Boca Raton, FL.
35. Plikaytis, B. D., P. F. Holder, and G. M. Carlone. 1996. Program ELISA for Windows user's manual, version 1.00. Centers for Disease Control and Prevention, Atlanta, GA.
36. Ross, J. M. 1957. The pathogenesis of anthrax following the administration of spores by the respiratory route. J. Pathol. Bacteriol. 73:485-494.
37. Scorpio, A., D. J. Chabot, W. A. Day, D. K. O'Brien, N. J. Vietri, Y. Itoh, M. Mohamadzadeh, and A. M. Friedlander. 2007. Poly-γ-glutamate capsule-degrading enzyme treatment enhances phagocytosis and killing of encapsulated Bacillus anthracis. Antimicrob. Agents Chemother. 51:215-222.
38. Semenova, V. A., E. Steward-Clark, K. L. Stamey, T. H. Taylor, Jr., D. S. Schmidt, S. K. Martin, N. Marano, and C. P. Quinn. 2004. Mass value assignment of total and subclass immunoglobulin G in a human standard anthrax reference serum. Clin. Diagn. Lab. Immunol. 11:919-923.
39. Shieh, W. J., J. Guarner, C. Paddock, P. Greer, K. Tatti, M. Fischer, M. Layton, M. Philips, E. Bresnitz, C. P. Quinn, T. Popovic, B. A. Perkins, and S. R. Zaki, and the Anthrax Bioterrorism Investigation Team. 2003. The critical role of pathology in the investigation of bioterrorism-related cutaneous anthrax. Am. J. Pathol. 163:1901-1910.
40. Soehnlein, O., E. Kenne, P. Rotzius, E. E. Eriksson, and L. Lindbom. 2008. Neutrophil secretion products regulate anti-bacterial activity in monocytes and macrophages. Clin. Exp. Immunol. 151:139-145.
41. Tang, S., M. Moayeri, Z. Chen, H. Harma, J. Zhao, H. Hu, R. H. Purcell, S. H. Leppla, and I. K. Hewlett. 2009. Detection of anthrax toxin by an ultrasensitive immunoassay using europium nanoparticles. Clin. Vaccine Immunol. 16:408-413.
42. Turk, B. E. 2007. Manipulation of host signaling pathways by anthrax toxins. Biochem. J. 402:405-417.
43. van Faassen, H., R. KuoLee, G. Harris, X. Zhao, J. W. Conlan, and W. Chen. 2007. Neutrophils play an important role in host resistance to respiratory infection with Acinetobacter baumannii in mice. Infect. Immun. 75:5597-5608.
44. Vietri, N. J., B. K. Purcell, S. A. Tobery, S. L. Rasmussen, E. K. Leffel, N. A. Twenhafel, B. E. Ivins, M. D. Kellogg, W. M. Webster, M. E. Wright, and A. M. Friedlander. 2009. A short course of antibiotic treatment is effective in preventing death from experimental inhalational anthrax after discontinuing antibiotics. J. Infect. Dis. 199:336-341.
45. Walsh, J. J., N. Pesik, C. P. Quinn, B. Urdaneta, C. A. Dykewicz, A. E. Boyer, J. Guarner, P. Wilkins, K. J. Norville, J. R. Barr, S. R. Zaki, J. B. Patel, S. P. Reagan, J. L. Pirkle, T. A. Treadwell, N. R. Messonnier, L. D. Rotz, R. F. R. F. Meyer, and D. S. Stephens. 2007. A case of naturally acquired inhalation anthrax: clinical care and analyses of anti-protective antigen immunoglobulin G and lethal factor. Clin. Infect. Dis. 44:968-971.
46. Wang, W., C. Mulakala, S. C. Ward, G. Jung, H. Luong, D. Pham, A. J. Waring, Y. Kaznessis, W. Lu, K. A. Bradley, and R. I. Lehrer. 2006. Retrocyclins kill bacilli and germinating spores of Bacillus anthracis and inactivate anthrax lethal toxin. J. Biol. Chem. 281:32755-32764.
47. Welkos, S. L., R. W. Trotter, D. M. Becker, and G. O. Nelson. 1989. Resistance to the Sterne strain of B. anthracis: phagocytic cell responses of resistant and susceptible mice. Microb. Pathog. 7:15-35.
48. Xu, L., and D. M. Frucht. 2007. Bacillus anthracis: a multi-faceted role for anthrax lethal toxin in thwarting host immune defenses. Int. J. Biochem. Cell Biol. 39:20-24.
49. Xu, Q., E. D. Hesek, and M. Zeng. 2007. Transcriptional stimulation of anthrax toxin receptors by anthrax edema toxin and Bacillus anthracis Sterne spore. Microb. Pathog. 43:37-45.
50. Zahorec, R. 2001. Ratio of neutrophil to lymphocyte counts: rapid and simple parameter of systemic inflammation and stress in critically ill. Bratisl. Lek. Listy. 102:5-14.